On 10 March 2014, CureVac has won a €2 million prize awarded by the European Commission to stimulate new vaccine technologies that might help the developing world, because the company's research could lead to a new generation of vaccines that don't need refrigeration.
On 10 March 2014, CureVac has won a €2 million prize awarded by the European Commission to stimulate new vaccine technologies that might help the developing world. Because the company's research could lead to a new generation of vaccines that don't need refrigeration.